Antibiotics

Nanocrystalline Silver Dressings Support Antimicrobial Stewardship

Nanocrystalline Silver Dressings Support Antimicrobial Stewardship

Antimicrobial resistance is an ever-increasing global concern, with the era of untreatable infection becoming a reality. Wound care is no exception, with increasing issues of antibiotic-resistant infections across different wound types and care settings. There is an urgent need for novel anti-biofilm strategies and novel antimicrobial agents and, in this scenario, silver nanotechnology has received tremendous attention in recent years in therapeutically enhanced healthcare.

Modern Medicine – Issue 4 2020

August 14, 2020 by Antibiotics Woundcare

Antimicrobial Stewardship – Some Strategies

Antimicrobial Stewardship – Some Strategies

Antimicrobial stewardship (AMS) has been touted as one of the key strategies required in tackling worldwide escalation of antibiotic resistance. Although AMS has optimised antibiotic usage and reduced the incidence of resistance development in some regions, it is evident at present that the worldwide rate of antibiotic resistance development has shown no sign of slowing down whilst the global consumption of antibiotics continues to rise over the years.

Modern Medicine – May/June 2018

July 9, 2018 by Antibiotics

The Antibiotic Resistance Time Bomb is Ticking

The Antibiotic Resistance Time Bomb is Ticking – MM1607

Antibiotic resistance is threatening modern medicine, with overuse and misuse of antibiotics driving resistance to such an extent that the world has entered the post-antibiotic era, where some multidrug- and pandrug-resistant bacterial infections are no longer treatable. If not addressed, 10m people will die annually of drug-resistant infections by 2050 with added interference to other common medical procedures that rely on antibiotics for their success.

Modern Medicine – July 2016

July 22, 2016 by Antibiotics Critical Care

Judicious Use of Linezolid for Drug-resistant Bacteria

Judicious Use of Linezolid for Drug-resistant Bacteria – MM1603

While the choices available for the management of grampositive, drug-resistant bacterial infections are becoming limited, antimicrobial resistance is becoming increasingly problematic because of the widespread overuse of antibiotics.

Linezolid is a synthetic antibiotic belonging to a class of antimicrobials called the oxazolidinones. Linezolid disrupts bacterial growth by inhibiting the initiation process of protein synthesis—a mechanism of action that is unique to this class of drugs.

Modern Medicine – March 2016

March 18, 2016 by Antibiotics Bacterial Infections Critical Care

Beyond Superbugs: Critical Lessons in Life and Medicine

Beyond Superbugs: Critical Lessons in Life and Medicine – MM1501

Infections and infectious diseases account for an exceedingly significant proportion of deaths that occur annually worldwide. The emergence of multi-drug resistant, extensively resistant and pan-resistant pathogens and the widespread inappropriate use of antibiotics is a global catastrophe receiving increasing attention by health care authorities.

Modern Medicine – January 2015

January 27, 2015 by Antibiotics

Effective Treatment of Gram-positive and Gram-negative Bacterial Infections

Effective Treatment of Gram-positive and Gram-negative Bacterial Infections – MM1308

Even common problems in antibiotic treatment do not have simple solutions. Choosing one antibiotic drug from among several candidates entails balancing the benefits and the drawbacks associated with each. The physician must strike the right balance between effectively treating the current infection and maintaining options for future use in the light of growing drug- resistance. Here are three antibiotics to consider.

Modern Medicine – August 2013

August 13, 2013 by Antibiotics Bacterial Infections
Verified by ExactMetrics